These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1247 related items for PubMed ID: 27678427

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND, Chuang J, Zhao Y, Rosenblit PD.
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
    Yeboah J, Polonsky TS, Young R, McClelland RL, Delaney JC, Dawood F, Blaha MJ, Miedema MD, Sibley CT, Carr JJ, Burke GL, Goff DC, Psaty BM, Greenland P, Herrington DM.
    Circulation; 2015 Sep 08; 132(10):916-22. PubMed ID: 26224808
    [Abstract] [Full Text] [Related]

  • 8. Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry.
    Maddox TM, Borden WB, Tang F, Virani SS, Oetgen WJ, Mullen JB, Chan PS, Casale PN, Douglas PS, Masoudi FA, Farmer SA, Rumsfeld JS.
    J Am Coll Cardiol; 2014 Dec 02; 64(21):2183-92. PubMed ID: 25447259
    [Abstract] [Full Text] [Related]

  • 9. Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study.
    Yang Q, Zhong Y, Gillespie C, Merritt R, Bowman B, George MG, Flanders WD.
    BMJ Open; 2017 Jan 24; 7(1):e011684. PubMed ID: 28119384
    [Abstract] [Full Text] [Related]

  • 10. Race and Socioeconomic Differences Associated With Changes in Statin Eligibility Under the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
    Verma AA, Jimenez MP, Subramanian SV, Sniderman AD, Razak F.
    Circ Cardiovasc Qual Outcomes; 2017 Sep 24; 10(9):. PubMed ID: 28912201
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness of Low-density Lipoprotein Cholesterol Level-Guided Statin Treatment in Patients With Borderline Cardiovascular Risk.
    Kohli-Lynch CN, Bellows BK, Thanassoulis G, Zhang Y, Pletcher MJ, Vittinghoff E, Pencina MJ, Kazi D, Sniderman AD, Moran AE.
    JAMA Cardiol; 2019 Oct 01; 4(10):969-977. PubMed ID: 31461121
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US.
    Marrett E, Zhao C, Zhang NJ, Zhang Q, Ramey DR, Tomassini JE, Tershakovec AM, Neff DR.
    Vasc Health Risk Manag; 2014 Oct 01; 10():237-46. PubMed ID: 24851051
    [Abstract] [Full Text] [Related]

  • 16. American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    Qureshi WT, Kaplan RC, Swett K, Burke G, Daviglus M, Jung M, Talavera GA, Chirinos DA, Reina SA, Davis S, Rodriguez CJ.
    J Am Heart Assoc; 2017 May 11; 6(5):. PubMed ID: 28495699
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of Cardiology/American Heart Association guidelines? A VOYAGER meta-analysis.
    Karlson BW, Palmer MK, Nicholls SJ, Lundman P, Barter PJ.
    Atherosclerosis; 2015 Aug 11; 241(2):450-4. PubMed ID: 26074319
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources: a retrospective analysis.
    Jones PH, Nair R, Thakker KM.
    J Am Heart Assoc; 2012 Dec 11; 1(6):e001800. PubMed ID: 23316314
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.